Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ammonium chloride + sodium citrate + citric acid is a combination pharmaceutical formulation used primarily as an expectorant to facilitate the removal of mucus from the respiratory tract. **Ammonium chloride** acts as a reflex expectorant by irritating the gastric mucosa, which in turn stimulates the vagal reflex to increase the volume of respiratory tract secretions, thereby thinning the mucus and making it easier to cough up. **Sodium citrate** and **citric acid** serve dual roles: they act as buffering agents to maintain the stability and pH of the liquid formulation, and they also possess mild mucolytic properties that help reduce the viscosity of bronchial secretions. This combination is a staple in over-the-counter (OTC) cough syrups and linctuses intended for the symptomatic relief of productive coughs associated with conditions such as the common cold, bronchitis, and other upper respiratory tract infections.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ammonium chloride + sodium citrate + citric acid.